Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis

Critical Care

Volumn 11, Issue 5, 2007, Pages

  Luce, Wendy A ^a   Hoffman, Timothy M ^a   Bauer, John Anthony ^a  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CATECHOLAMINE; CORTICOSTEROID DERIVATIVE; CYTOKINE; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; DROTRECOGIN; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INOTROPIC AGENT; INSULIN; MILRINONE; NITRIC OXIDE; NORADRENALIN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; RECOMBINANT COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ABSENCE OF SIDE EFFECTS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE PREDISPOSITION; DRUG FATALITY; DRUG MEGADOSE; FLUID RESUSCITATION; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INNATE IMMUNITY; LACTATE BLOOD LEVEL; LOW DRUG DOSE; NEUROLOGIC DISEASE; NEUTROPHIL; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; ADULT; AGE; COMPARATIVE STUDY; IMMUNOLOGY; INFLAMMATION; NEWBORN; SEPSIS;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; HUMANS; IMMUNITY, NATURAL; INFANT, NEWBORN; INFLAMMATION; SEPSIS; TREATMENT OUTCOME;

EID: 44449087102     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6091     Document Type: Review

References (119)

1. Vincent JL Sakr Y Sprung CL Ranieri VM Reinhart K Gerlach H Moreno R Carlet J Le Gall JR Payen D Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006, 34:344-353. 10.1097/ 01.CCM.0000194725.48928.3A 16424713
2. Angus DC Linde-Zwirble WT Lidicker J Clermont G Carcillo J Pinsky MR Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002 11445675
3. Watson RS Carcillo JA Linde-Zwirble WT Clermont G Lidicker J Angus DC The epidemiology of severe sepsis in children in the United States Am J Respir Crit Care Med 2003, 167:695-701. 10.1164/rccm.200207-682OC 12433670
4. Meadow W Frain L Ren Y Lee G Soneji S Lantos J Serial assessment of mortality in the neonatal intensive care unit by algorithm and intuition: Certainty, uncertainty, and informed consent Pediatrics 2002, 109:878-886. 10.1542/peds.109.5.878 11986450
5. Stoll BJ Hansen N Fanaroff AA Wright LL Carlo WA Ehrenkranz RA Lemons JA Donovan EF Stark AR Tyson JE et al.: Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network Pediatrics 2002, 110:285-291. 10.1542/peds.110.2.285 12165580
6. Evans N Which inotrope for which baby? Arch Dis Child Fetal Neonatal Ed 2006, 91:F213-F220. 10.1136/adc.2005.071829 16632650
7. Fagoaga OR Nehlsen-Cannarella SL Maternal modulation of neonatal immune system development Dev Immunol 2002, 9:9-17. 10.1080/10446670290030972 12353663
8. Aaltonen R Heikkinen T Hakala K Laine K Alanen A Transfer of proinflammatory cytokines across term placenta Obstet Gynecol 2005, 106:802-807. 16199639
9. Mohan AR Loudon JA Bennett PR Molecular and biochemical mechanisms of preterm labour Semin Fetal Neonatal Med 2004, 9:437-444. 10.1016/ j.siny.2004.08.001 15691781
10. Molloy EJ O'Neill AJ Grantham JJ Sheridan-Pereira M Fitzpatrick JM Webb DW Watson RW Labor promotes neonatal neutrophil survival and lipopolysaccharide responsiveness Pediatr Res 2004, 56:99-103. 10.1203/ 01.PDR.0000130473.30874.B6 15128917
11. Gessler P Dahinden C Increased respiratory burst and increased expression of complement receptor-3 (CD11b/CD18) and of IL-8 receptor-A in neutrophil granulocytes from newborns after vaginal delivery Biol Neonate 2003, 83:107-112. 10.1159/000067962 12576754
12. Bozza FA Salluh JI Japiassu AM Soares M Assis EF Gomes RN Bozza MT Castro-Faria-Neto HC Bozza PT Cytokine profiles as markers of disease severity in sepsis: A multiplex analysis Crit Care 2007, 11:R49. 10.1186/ cc5783 17448250
13. Rangel-Frausto MS Sepsis: Still going strong Arch Med Res 2005, 36:672-681. 10.1016/j.arcmed.2005.06.006 16216648
14. Schultz C Temming P Bucsky P Gopel W Strunk T Hartel C Immature anti-inflammatory response in neonates Clin Exp Immunol 2004, 135:130-136. 1808915 14678274 10.1111/j.1365-2249.2004.02313.x
15. Kox WJ Volk T Kox SN Volk HD Immunomodulatory therapies in sepsis Intensive Care Med 2000, 26(Suppl 1):S124-S128. 10.1007/s001340051129 10786969
16. Bone RC Sir Isaac Newton, sepsis, SIRS, and CARS Crit Care Med 1996, 24:1125-1128. 10.1097/00003246-199607000-00010 8674323
17. Platzer C Meisel C Vogt K Platzer M Volk HD Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs Int Immunol 1995, 7:517-523. 10.1093/intimm/7.4.517 7547677
18. Kox WJ Bone RC Krausch D Docke WD Kox SN Wauer H Egerer K Querner S Asadullah K von Baehr R et al.: Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: Proof of principle Arch Intern Med 1997, 157:389-393. 10.1001/ archinte.157.4.389 9046890
19. Takala A Nupponen I Kylanpaa-Back ML Repo H Markers of inflammation in sepsis Ann Med 2002, 34:614-623. 10.1080/078538902321117841 12553502
20. Strunk T Temming P Gembruch U Reiss I Bucsky P Schultz C Differential maturation of the innate immune response in human fetuses Pediatr Res 2004, 56:219-226. 10.1203/01.PDR.0000132664.66975.79 15181184
21. Schultz C Rott C Temming P Schlenke P Moller JC Bucsky P Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants Pediatr Res 2002, 51:317-322. 10.1203/00006450-200203000-00009 11861936
22. Dembinski J Behrendt D Martini R Heep A Bartmann P Modulation of pro- and anti-inflammatory cytokine production in very preterm infants Cytokine 2003, 21:200-206. 10.1016/S1043-4666(02)00498-2 12788309
23. Ohls RK Li Y Abdel-Mageed A Buchanan G Jr Mandell L Christensen RD Neutrophil pool sizes and granulocyte colony-stimulating factor production in human mid-trimester fetuses Pediatr Res 1995, 37:806-811. 10.1203/00006450-199506000-00022 7544455
24. Carr R Huizinga TW Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonates [letter] Arch Dis Child Fetal Neonatal Ed 2000, 83:F160. 10.1136/fn.83.2.F160 11012271
25. Molloy EJ O'Neill AJ Grantham JJ Sheridan-Pereira M Fitzpatrick JM Webb DW Watson RW Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function Pediatr Res 2005, 57:806-812. 10.1203/01.PDR.0000156500.13600.B5 15718363
26. Weinberger B Laskin DL Mariano TM Sunil VR DeCoste CJ Heck DE Gardner CR Laskin JD Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants J Leukoc Biol 2001, 70:969-976. 11739560
27. Nybo M Sorensen O Leslie R Wang P Reduced expression of C5a receptors on neutrophils from cord blood Arch Dis Child Fetal Neonatal Ed 1998, 78:F129-F132. 9577284
28. Carr R Neutrophil production and function in newborn infants Br J Haematol 2000, 110:18-28. 10.1046/j.1365-2141.2000.01992.x 10930976
29. Nupponen I Turunen R Nevalainen T Peuravuori H Pohjavuori M Repo H Andersson S Extracellular release of bactericidal/ permeability-increasing protein in newborn infants Pediatr Res 2002, 51:670-674. 12032259
30. von Rosenstiel N von Rosenstiel I Adam D Management of sepsis and septic shock in infants and children Paediatr Drugs 2001, 3:9-27. 10.2165/ 00128072-200103010-00002 11220406
31. Huttenbach Y Ostrowski ML Thaller D Kim HS Cell proliferation in the growing human heart: MIB-1 immunostaining in preterm and term infants at autopsy Cardiovasc Pathol 2001, 10:119-123. 10.1016/ S1054-8807(01)00065-5 11485855
32. 2+ transients in beating rat hearts Am J Physiol Heart Circ Physiol 2004, 286:H971-H978. 10.1152/ajpheart.00308.2003 14644760
33. Wetzel GT Chen F Klitzner TS L- and T-type calcium channels in acutely isolated neonatal and adult cardiac myocytes Pediatr Res 1991, 30:89-94. 1653937
34. 2+ channel function and expression in neonatal rabbit ventricular myocytes Am J Physiol Heart Circ Physiol 2006, 290:H2267-H2276. 10.1152/ajpheart.01093.2005 16339821
35. + channel subunits during perinatal maturation in the mouse heart Pediatr Res 2005, 58:185-192. 10.1203/01.PDR.0000169967.83576.CB 16085792
36. Kuznetsov V Pak E Robinson RB Steinberg SF Beta 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes Circ Res 1995, 76:40-52. 8001277
37. Kumar A Kumar A Paladugu B Mensing J Parrillo JE Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum Crit Care Med 2007, 35:358-364. 10.1097/01.CCM.0000254341.87098.A4 17204997
38. Khadour FH Panas D Ferdinandy P Schulze C Csont T Lalu MM Wildhirt SM Schulz R Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats Am J Physiol Heart Circ Physiol 2002, 283:H1108-H1115. 12181141
39. Watts JA Kline JA Thornton LR Grattan RM Brar SS Metabolic dysfunction and depletion of mitochondria in hearts of septic rats J Mol Cell Cardiol 2004, 36:141-150. 10.1016/j.yjmcc.2003.10.015 14734056
40. Carcillo JA Pediatric septic shock and multiple organ failure Crit Care Clin 2003, 19:413-440, viii. 10.1016/S0749-0704(03)00013-7 12848313
41. Kumar A Kumar A Michael P Brabant D Parissenti AM Ramana CV Xu X Parrillo JE Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes J Biol Chem 2005, 280:42619-42626. 10.1074/ jbc.M508416200 16223733
42. Comstock KL Krown KA Page MT Martin D Ho P Pedraza M Castro EN Nakajima N Glembotski CC Quintana PJ, et al.: LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response J Mol Cell Cardiol 1998, 30:2761-2775. 10.1006/jmcc.1998.0851 9990546
43. Lancel S Petillot P Favory R Stebach N Lahorte C Danze PM Vallet B Marchetti P Neviere R Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats Crit Care Med 2005, 33:492-496. 10.1097/01.CCM.0000156240.31913.4A 15753737
44. Hickson-Bick DL Jones C Buja LM The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress Shock 2006, 25:546-552. 10.1097/01.shk.0000209549.03463.91 16680021
45. Maeder M Fehr T Rickli H Ammann P Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides Chest 2006, 129:1349-1366. 10.1378/chest.129.5.1349 16685029
46. Tabbutt S Heart failure in pediatric septic shock: Utilizing inotropic support Crit Care Med 2001, 29:S231-S236. 10.1097/ 00003246-200110001-00005 11593066
47. Belcher E Mitchell J Evans T Myocardial dysfunction in sepsis: No role for NO? Heart 2002, 87:507-509. 1767140 12010927 10.1136/heart.87.6.507
48. Krishnagopalan S Kumar A Parrillo JE Kumar A Myocardial dysfunction in the patient with sepsis Curr Opin Crit Care 2002, 8:376-388. 10.1097/ 00075198-200210000-00003 12357104
49. Mercier JC Beaufils F Hartmann JF Azema D Hemodynamic patterns of meningococcal shock in children Crit Care Med 1988, 16:27-33. 10.1097/ 00003246-198801000-00006 3338278
50. McKiernan CA Lieberman SA Circulatory shock in children: An overview Pediatr Rev 2005, 26:451-460. 16327026
51. Ceneviva G Paschall JA Maffei F Carcillo JA Hemodynamic support in fluid-refractory pediatric septic shock Pediatrics 1998, 102:e19. [doi:10.1542/peds.102.2.e19] 10.1542/peds.102.2.e19 9685464
52. Carcillo JA Fields AI Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock Crit Care Med 2002, 30:1365-1378. 10.1097/00003246-200206000-00040 12072696
53. Pollack MM Fields AI Ruttimann UE Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock Crit Care Med 1985, 13:454-459. 10.1097/00003246-198506000-00002 3995997
54. Kluckow M Evans N Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation J Pediatr 1996, 129:506-512. 10.1016/S0022-3476(96)70114-2 8859256
55. Crepaz R Pitscheider W Radetti G Gentili L Age-related variation in left ventricular myocardial contractile state expressed by the stress velocity relation Pediatr Cardiol 1998, 19:463-467. 10.1007/ s002469900358 9770572
56. Toyono M Harada K Takahashi Y Takada G Maturational changes in left ventricular contractile state Int J Cardiol 1998, 64:247-252. 10.1016/ S0167-5273(98)00047-3 9672404
57. Joyce JJ Dickson PI Qi N Noble JE Raj JU Baylen BG Normal right and left ventricular mass development during early infancy Am J Cardiol 2004, 93:797-801. 10.1016/j.amjcard.2003.11.063 15019899
58. Marijianowski MM van der Loos CM Mohrschladt MF Becker AE The neonatal heart has a relatively high content of total collagen and type I collagen, a condition that may explain the less compliant state J Am Coll Cardiol 1994, 23:1204-1208. 8144790
59. Kozak-Barany A Jokinen E Saraste M Tuominen J Valimaki I Development of left ventricular systolic and diastolic function in preterm infants during the first month of life: A prospective follow-up study J Pediatr 2001, 139:539-545. 10.1067/mpd.2001.118199 11598601
60. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001, 345:1368-1377. 10.1056/ NEJMoa010307 11794169
61. Tarnow-Mordi WO What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis? Pediatr Crit Care Med 2005, 6:S135-S137. 10.1097/01.PCC.0000161581.42668.5E 15857546
62. Cartwright K Reilly S White D Stuart J Early treatment with parenteral penicillin in meningococcal disease BMJ 1992, 305:143-147. 1883180 1515827
63. Houck PM Bratzler DW Nsa W Ma A Bartlett JG Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 2004, 164:637-644. 10.1001/ archinte.164.6.637 15037492
64. Iregui M Ward S Sherman G Fraser VJ Kollef MH Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest 2002, 122:262-268. 10.1378/ chest.122.1.262 12114368
65. So KW Fok TF Ng PC Wong WW Cheung KL Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants Arch Dis Child Fetal Neonatal Ed 1997, 76:F43-F46. 9059186
66. Upadhyay M Singhi S Murlidharan J Kaur N Majumdar S Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock Indian Pediatr 2005, 42:223-231. 15817970
67. Su F Wang Z Cai Y Rogiers P Vincent JL Fluid resuscitation in severe sepsis and septic shock: Albumin, hydroxyethyl starch, gelatin or ringer's lactate - does it really make a difference? Shock 2007, 27:520-526. 10.1097/01.shk.0000248583.33270.12 17438457
68. Finfer S Bellomo R Boyce N French J Myburgh J Norton R A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 2004, 350:2247-2256. 10.1056/NEJMoa040232 15163774
69. Hollenberg SM Ahrens TS Annane D Astiz ME Chalfin DB Dasta JF Heard SO Martin C Napolitano LM Susla GM et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update Crit Care Med 2004, 32:1928-1948. 10.1097/01.CCM.0000139761.05492.D6 15343024
70. Beale RJ Hollenberg SM Vincent JL Parrillo JE Vasopressor and inotropic support in septic shock: An evidence-based review Crit Care Med 2004, 32:S455-S465. 10.1097/01.CCM.0000142909.86238.B1 15542956
71. Longin E Gerstner T Schaible T Lenz T Konig S Maturation of the autonomic nervous system: Differences in heart rate variability in premature vs. term infants J Perinat Med 2006, 34:303-308. 10.1515/ JPM.2006.058 16856820
72. Hirsimaki H Kero P Ekblad H Scheinin M Saraste M Erkkola R Mode of delivery, plasma catecholamines and Doppler-derived cardiac output in healthy term newborn infants Biol Neonate 1992, 61:285-293. 1391254
73. Kallio J Karlsson R Toppari J Helminen T Scheinin M Kero P Antenatal dexamethasone treatment decreases plasma cate-cholamine levels in preterm infants Pediatr Res 1998, 43:801-807. 10.1203/ 00006450-199806000-00014 9621991
74. Newnham JP Marshall CL Padbury JF Lam RW Hobel CJ Fisher DA Fetal catecholamine release with preterm delivery Am J Obstet Gynecol 1984, 149:888-893. 6465254
75. Teitel DF Sidi D Chin T Brett C Heymann MA Rudolph AM Developmental changes in myocardial contractile reserve in the lamb Pediatr Res 1985, 19:948-955. 10.1203/00006450-198509000-00017 4047765
76. Valverde E Pellicer A Madero R Elorza D Quero J Cabanas F Dopamine versus epinephrine for cardiovascular support in low birth weight infants: Analysis of systemic effects and neonatal clinical outcomes Pediatrics 2006, 117:e1213-e1222. 10.1542/peds.2005-2108 16717120
77. Osborn D Evans N Kluckow M Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow J Pediatr 2002, 140:183-191. 10.1067/mpd.2002.120834 11865269
78. Barton P Garcia J Kouatli A Kitchen L Zorka A Lindsay C Lawless S Giroir B Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study Chest 1996, 109:1302-1312. 8625683
79. Hoffman TM Wernovsky G Atz AM Kulik TJ Nelson DP Chang AC Bailey JM Akbary A Kocsis JF Kaczmarek R et al.: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 2003, 107:996-1002. 10.1161/01.CIR.0000051365.81920.28 12600913
80. Bailey JM Hoffman TM Wessel DL Nelson DP Atz AM Chang AC Kulik TJ Spray TL Akbary A Miller RP et al.: A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery J Pharmacokinet Pharmacodyn 2004, 31:43-59. 10.1023/B:JOPA.0000029488.45177.48 15346851
81. Guignard JP Torrado A Da Cunha O Gautier E Glomerular filtration rate in the first three weeks of life J Pediatr 1975, 87:268-272. 10.1016/ S0022-3476(75)80600-7 1151567
82. Bueva A Guignard JP Renal function in preterm neonates Pediatr Res 1994, 36:572-577. 7877873
83. Vanpee M Blennow M Linne T Herin P Aperia A Renal function in very low birth weight infants: Normal maturity reached during early childhood J Pediatr 1992, 121:784-788. 10.1016/S0022-3476(05)81916-X 1432434
84. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001 11236773
85. Cvirn G Koestenberger M Leschnik B Male C Kutschera J Ferstl U Muntean W Juergens G Gallistl S Protein S modulates the anticoagulant action of recombinant human activated protein C: A comparison between neonates and adults Br J Pharmacol 2005, 146:1082-1086. 10.1038/sj.bjp.0706436 16273121
86. Zeni F Freeman B Natanson C Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment Crit Care Med 1997, 25:1095-1100. 10.1097/00003246-199707000-00001 9233726
87. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troche G et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002, 288:862-871. 10.1001/jama.288.7.862 12186604
88. Pizarro CF Troster EJ Damiani D Carcillo JA Absolute and relative adrenal insufficiency in children with septic shock Crit Care Med 2005, 33:855-859. 10.1097/01.CCM.0000159854.23324.84 15818116
89. Markovitz BP Goodman DM Watson RS Bertoch D Zimmerman J A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: What is the role of steroids? Pediatr Crit Care Med 2005, 6:270-274. 10.1097/01.PCC.0000160596.31238.72 15857523
90. Bourchier D Weston PJ Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants Arch Dis Child Fetal Neonatal Ed 1997, 76:F174-F178. 9175947
91. Noori S Siassi B Durand M Acherman R Sardesai S Ramanathan R Cardiovascular effects of low-dose dexamethasone in very low birth weight neonates with refractory hypotension Biol Neonate 2006, 89:82-87. 10.1159/000088289 16158007
92. Yeh TF Lin YJ Lin HC Huang CC Hsieh WS Lin CH Tsai CH Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity N Engl J Med 2004, 350:1304-1313. 10.1056/NEJMoa032089 15044641
93. Bell SG Immunomodulation, part I: Pentoxifylline Neonatal Netw 2005, 24:45-48. 16117244
94. Lauterbach R Pawlik D Kowalczyk D Ksycinski W Helwich E Zembala M Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial Crit Care Med 1999, 27:807-814. 10.1097/ 00003246-199904000-00042 10321674
95. Bacher A Mayer N Klimscha W Oismuller C Steltzer H Hammerle A Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients Crit Care Med 1997, 25:795-800. 10.1097/ 00003246-199705000-00014 9187598
96. Staubach KH Schroder J Stuber F Gehrke K Traumann E Zabel P Effect of pentoxifylline in severe sepsis: Results of a randomized, double-blind, placebo-controlled study Arch Surg 1998, 133:94-100. 10.1001/ archsurg.133.1.94 9438767
97. Giroir BP Recombinant human activated protein C for the treatment of severe sepsis: Is there a role in pediatrics? Curr Opin Pediatr 2003, 15:92-96. 10.1097/00008480-200302000-00015 12544278
98. Nadel S Goldstein B Williams MD Dalton H Peters M Macias WL Abd-Allah SA Levy H Angle R Wang D Drotrecogin alfa (activated) in children with severe sepsis: A multicentre phase III randomised controlled trial Lancet 2007, 369:836-843. 10.1016/S0140-6736(07)60411-5 17350452
99. Spitzer AR Kirkby S Kornhauser M Practice variation in suspected neonatal sepsis: A costly problem in neonatal intensive care J Perinatol 2005, 25:265-269. 10.1038/sj.jp.7211252 15616610
100. Tarnow-Mordi WO What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis? Pediatr Crit Care Med 2005, 6(3 Suppl):S135-S137. 10.1097/01.PCC.0000161581.42668.5E 15857546
101. LaRosa SP Use of corticosteroids in the sepsis syndrome: What do we know now? Cleve Clin J Med 2005, 72:1121-1127. 16392726
102. Annane D Bellissant E Bollaert PE Briegel J Keh D Kupfer Y Corticosteroids for severe sepsis and septic shock: A systematic review and meta-analysis BMJ doi:10.1136/bmj.38181. 482222.55 (published 2 August 2004) 515196 15289273
103. Ohlsson A Lacy JB Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants Cochrane Database Syst Rev 2004 1 Art. No.: CD000361. DOI: 10.1002/14651858.CD000361.pub2. 14973955
104. Ohlsson A Lacy JB Intravenous immunoglobulin for suspected or subsequently proven infection in neonates Cochrane Database Syst Rev 2004 1 Art. No.: CD001239. DOI: 10.1002/14651858.CD001239.pub2. 14973965
105. Alejandria MM Lansang MA Dans LF Mantaring JB Intravenous immunoglobulin for treating sepsis and septic shock Cochrane Database Syst Rev 2002 1 Art. No.: CD001090. DOI: 10.1002/14651858.CD001090. 11869591
106. Bell SG Immunomodulation, part II: Granulocyte colony-stimulating factors Neonatal Netw 2006, 25:65-70. 16514867
107. Carr R Modi N Dore C G-CSF and GM-CSF for treating or preventing neonatal infections Cochrane Database Syst Rev 2003 3 Art. No.: CD003066. DOI: 10.1002/14651858.CD003066. 12917944
108. Root RK Lodato RF Patrick W Cade JF Fotheringham N Milwee S Vincent JL Torres A Rello J Nelson S Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis Crit Care Med 2003, 31:367-373. 10.1097/ 01.CCM.0000048629.32625.5D 12576938
109. Wunderink R Leeper K Jr Schein R Nelson S DeBoisblanc B Fotheringham N Logan E Filgrastim in patients with pneumonia and severe sepsis or septic shock Chest 2001, 119:523-529. 10.1378/chest.119.2.523 11171733
110. Stephens DP Fisher DA Currie BJ An audit of the use of granulocyte colony-stimulating factor in septic shock Intern Med J 2002, 32:143-148. 10.1046/j.1445-5994.2002.00195.x 11951925
111. Garcia-Carbonero R Mayordomo JI Tornamira MV Lopez-Brea M Rueda A Guillem V Arcediano A Yubero A Ribera F Gomez C et al.: Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial J Natl Cancer Inst 2001, 93:31-38. 10.1093/jnci/93.1.31 11136839
112. Presneill JJ Harris T Stewart AG Cade JF Wilson JW A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction Am J Respir Crit Care Med 2002, 166:138-143. 10.1164/rccm.2009005 12119223
113. Rosenbloom AJ Linden PK Dorrance A Penkosky N Cohen-Melamed MH Pinsky MR Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients Chest 2005, 127:2139-2150. 10.1378/chest.127.6.2139 15947332
114. Frommhold D Birle A Linderkamp O Zilow E Poschl J Drotrecogin alpha (activated) in neonatal septic shock Scand J Infect Dis 2005, 37:306-308. 10.1080/00365540510031412 15804668
115. Kylat RI Ohlsson A Recombinant human activated protein C for severe sepsis in neonates Cochrane Database Syst Rev 2006 2 Art. No.: CD005385. DOI: 10.1002/14651858.CD005385.pub2. 16625638
116. Rawicz M Sitkowska B Rudzinska I Kornacka MK Bochenski P Recombinant human activated protein C for severe sepsis in a neonate Med Sci Monit 2002, 8:CS90-CS94. 12444386
117. Green C Dinnes J Takeda AL Cuthbertson BH Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom Int J Technol Assess Health Care 2006, 22:90-100. 16673685
118. Abraham E Laterre PF Garg R Levy H Talwar D Trzaskoma BL Francois B Guy JS Bruckmann M Rea-Neto A et al.: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death N Engl J Med 2005, 353:1332-1341. 10.1056/NEJMoa050935 16192478
119. Haque K Mohan P Pentoxifylline for neonatal sepsis Cochrane Database Syst Rev 2003 4 Art. No.: CD004205. DOI: 10.1002/14651858.CD004205. 14584009